menu
Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

A growing body ofevidence suggests that using psychedelics, such as psilocybin and LSD, incombination with psychotherapy, can treat the symptoms of several mental healthconditions, including depression and substance use disorders

 

Roots Analysis has announced theaddition of GlobalPsychedelic Therapeutics Market,2020-2030” report to its list ofofferings.

 

The report features an extensive study of thecurrent market landscape, offering an informed opinion on the likely adoptionof these therapies over the next decade. It features an in-depth analysis,highlighting the capabilities of various stakeholders engaged in this domain.In addition to other elements, the study includes:

§ A detailed assessmentof the current market landscape of drug developers engaged in the developmentof psychedelic therapeutics. 

§ Tabulated profiles ofprominent psychedelic therapeutics developers. shortlisted on the basis of thenumber of pipeline products).

§ Detailed profiles ofdevelopers of next generation immune checkpoint modulators (shortlisted onthe basis having two or more psychedelics-based therapies in phase II clinicalstudies and above).

§ An insightfulanalysis of clinical trial sites where the studies have been / are beingconducted for evaluation of various psychedelic therapeutics.

§ A list of key opinionleaders (KOLs) within this domain, and detailed 2×2 matrices to assess therelative experience of key individuals who were shortlisted based on theircontributions (in terms of involvement in various clinical studies) to thisfield.

§ A detailed analysisof nearly 545 grants that have been awarded to research institutes engaged inpsychedelic therapeutics projects, in the period between 2015 and 2020 (tillMay).

§ An analysis of thepartnerships that have been established in the recent past (2017-2020 tillMay),

§ A detailed analysisof the various mergers and acquisitions that have taken place in this domain,highlighting the trend in the number of companies acquired between 2017-2020.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

§  TargetDisease Indication

§ Anxiety andDepression

§ Trauma

§ Pain Disorder

§ Sleep relatedDisorder

§  Originof Psychedelic Substance

§ Natural

§ Synthetic

§  Typeof Psychedelic Substance

§ Gamma-hydroxybutyrate

§ Ketamine

§ MDMA

§ Psilocybin

§  Routeof Administration

§ Oral

§ Intranasal

§ Sublingual

§  KeyGeographies

§ North America

§ Europe

§ Asia-Pacific

Transcripts of interviews heldwith the following senior level representatives of stakeholder companies

§  AndrewChadeayne (Founder & Chief Executive Officer, CaaMTech)

§ Janakan Krishnarajah (ChiefOperating Officer and Chief Medical Officer, iX Biopharma)

§ Alexander Speiser (ChiefOperating Officer, Orthogonal Thinker)

§ Tracy Cheung, (ChiefCommunications Officer, COMPASS Pathways)

Keycompanies covered in the report 

§ Celon Pharma

§ iX Biopharma

§ MAPS Public Benefit

§ MindMed

§ Janssen Pharmaceuticals

§ Jazz Pharmaceutical

 

For additional details, pleasevisit 
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.htmlor email sales@rootsanalysis.com

 

You may also be interested in thefollowing titles: 

1.     EndocannabinoidSystem Targeted Therapeutics Market, 2020-2030

2.     DepressiveDisorders (Major Depression, Bipolar Disorder, Postpartum Depression,Treatment-Resistant Depression and Others): Pipeline Review, DeveloperLandscape and Competitive Insights, 2019

3.     Alzheimer'sDisease: Pipeline Review, Developer Landscape and Competitive Insights

4.     NeoantigenTargeted Therapies Market, 2019-2030

5.     Blood-BrainBarrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive DrugDelivery Technology Platforms and Therapeutics

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com